Positron forges Agent Agreement with Technology Imaging Services

Positron Corporation (OTCBB:POSC) (the “Company”), a molecular imaging solutions company focused on Nuclear Cardiology, announced today that they have executed an Agent Agreement with TIS – Technology Imaging Services. TIS offers a wide range of solutions for Nuclear Cardiology, Oncology, and Cardiac PET, including hot lab set up and products.

“We are excited to enter into this agreement with the TIS organization. TIS' reputation for service, support and daily interaction with their customers gives Positron and its products exposure throughout the PET Industry,” states Mark H. Wilson, Director of Business Development. “By joining with TIS, it gives both of our groups an opportunity to introduce and offer our Tech-Assist™ exposure control dose administration device, and our Attrius™ Cardiac optimized PET Scanner. We feel confident we are adding quality and innovative products to their overall Nuclear Cardiology and PET solutions.”

“With its Tech-Assist and the new Attrius Cardiac PET Scanner, Positron offers some of the most refined, detailed and comprehensive products available to the PET diagnostic imaging market. TIS is pleased to be able to bring these products to our clients in the Cardiology and PET modalities. This relationship is a win-win for both companies, but more important, it is a huge win for Cardiology and PET facilities nationwide,” states Kymberlie Stutz, Director of Nuclear Medicine Sales.

http://www.positron.com